Exact Sciences Corp
N/A
USD
N/A
N/A
...
Chart
Financials
Description
EXAS Company Description
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.
EXAS Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view EXAS Smart Score
Score Breakdown
EXAS Company Description
Show More
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of EXAS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by EXAS's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on EXAS's company Twitter account
WallStreetBets
Number of mentions of EXAS in WallStreetBets Daily Discussion
EXAS News
Recent insights relating to EXAS
CNBC Recommendations
Recent picks made for EXAS stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in EXAS
Corporate Flights
Flights by private jets registered to EXAS
Our Analysis